Efficacy and safety of dapagliflozin over 1 year as add-on to insulin therapy in Japanese patients with type 2 diabetes: the DAISY (Dapagliflozin Added to patients under InSulin therapY) trial
2017 ◽
Vol 19
(4)
◽
pp. 562-570
◽
Keyword(s):
Keyword(s):
2018 ◽
Vol 20
(10)
◽
pp. 2490-2493
◽
2018 ◽
Vol 34
(6)
◽
pp. 981-994
◽
Keyword(s):
2016 ◽
Vol 7
(4)
◽
pp. 555-564
◽
Keyword(s):
Keyword(s):
Keyword(s):
2017 ◽
Vol 19
(8)
◽
pp. 1188-1192
◽
Keyword(s):
2014 ◽
Vol 16
(11)
◽
pp. 1102-1110
◽